Radnet Receives a Hold from Jefferies

By Jason Carr

Jefferies analyst Brian Tanquilut maintained a Hold rating on Radnet (NASDAQ: RDNT) yesterday and set a price target of $7. The company’s shares closed yesterday at $6.40.

According to TipRanks.com, Tanquilut is ranked 0 out of 5 stars with an average return of -10.5% and a 34.0% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Five Star Quality Care, Quest Diagnostics Inc., and U.S. Physical Therapy.

Radnet has an analyst consensus of Hold.

The company has a one year high of $7.98 and a one year low of $4.66. Currently, Radnet has an average volume of 121.2K.

Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock. Most recently, in September 2016, Stephen Forthuber, the EVP of RDNT sold 20,000 shares for a total of $143,600.

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The company offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy and other related procedures. RadNet was founded by Howard Berger in 1980 and is headquartered in Los Angeles, CA.